查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1284224

到 2028 年的電生理學市場預測——按產品、適應症（房室結折返性心動過速、心房顫動、其他適應症）、最終用戶和地區進行的全球分析

Electrophysiology Market Forecasts to 2028 - Global Analysis By Product, Indication (Atrioventricular Nodal Reentry Tachycardia, Atrial fibrillation and Other Indications), End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 175+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2022 年全球電生理學市場規模將達到 75.7 億美元，預計到 2028 年將達到 144.7 億美元，預測期內復合年增長率為 11。預計增長速度為.4%。

電生理學 (EP) 是研究體內電活動的科學領域。 也稱為侵入性心臟電生理學，它是一系列分析心臟電活動的測試。 它通過測量心臟的電系統和活動來診斷和治療心律失常和心律失常。 該測試使用導管和線電極來評估通向心臟的血管的電活動。

根據 2022 年世界肥胖地圖集，到 2030 年，美洲三分之一的男性 (34.41%) 和近五分之二的女性 (39.72%) 的 BMI 預計將達到 30 公斤/平方米。

市場動態

驅動程序：

心律失常、眼部問題和癲癇的患病率增加

由於冷凍消融、激光消融、超聲消融和增強映射技術等創新技術的引入，預計全球電生理學市場在預測期內將會增長。 由於吸煙和過量飲酒等生活方式的選擇，千禧一代心力衰竭 (HF) 和心臟驟停病例的增加也推動了市場的發展。 此外，EP 監測系統的小型化增加了全球電生理行業對這些設備的需求，尤其是在 COVID-19 期間。 因此，心律和殘疾部門密切關注植入式電生理 (EP) 設備的遠程監控和編程能力。

約束

成本高

建立 EP 實驗室的成本多年來顯著上升，原因包括醫療保健提供者的整合、複雜醫療程序的使用導致成本增加、政府法規不斷變化以及資源限制等。 儘管各國對心律失常的認識和電生理產品在心律失常治療中的作用不斷增加，但這限制了這些產品的廣泛使用。

機會

新興市場增長

由於患者數量增加、心臟測繪系統普及、心血管疾病意識增強、可支配收入增加、醫療保健基礎設施改善以及與發達國家相比相對寬鬆的指導方針，新興市場正在蓬勃發展。預計將為這個市場的玩家。 在過去十年中，由於患者人數增加、心血管疾病相關死亡人數增加以及醫療旅遊增加，新興市場的外科手術數量穩步增加。

威脅

翻新設備

對翻新產品不斷增長的需求對市場進入者，尤其是小型生產商構成了重大挑戰。 為了提高市場地位並為電生理產品建立重要的用戶群，市場參與者可能會降低價格或採用更好或更先進的技術來滿足未滿足的市場需求。

COVID-19 的影響：

COVID-19 的意外爆發對全球醫療器械業務產生了各種影響。 由於全球醫院就診人數下降，某些類別總體上受到了負面影響。 另一方面，感染 COVID-19 的既往心髒病患者更有可能發生心髒病發作或充血性心力衰竭。 這種減少限制了對電生理設備的需求並阻礙了市場增長。 此外，在市場上運營的主要市場參與者在 2020 年上半年見證了這些設備產生的收入下降。

預計 EP 實驗室儀器部分在預測期內將成為最大的部分

EP 實驗室儀器部門的推動因素包括用於開發新型電生理記錄系統的公共和私人資金增加、射頻消融手術數量的增加、射頻消融手術與其他消融技術相比的成本效益、有利的增長是預計，部分原因是這些產品的可用性增加 EP 實驗室設備進一步細分為 EP X 射線系統、3D 映射系統、EP 記錄系統、EP 遠程控制系統等。

房顫 (AF) 部分預計在預測期內的複合年增長率最高

房顫 (AF) 部分預計將在預測期內實現最高的複合年增長率。 心房顫動 (AF)，通常稱為 AFib，是最常見的心律失常之一，會導致不規則、快速的心律。 在心房顫動中，心臟的上腔室迅速收縮，阻礙了血液從心房到心室的正常泵送，導致血栓形成。 房顫患者更容易出現嚴重的心臟問題，例如中風和心力衰竭。 據說心房顫動會導致大約六分之一的人中風。

市場份額最高的地區

由於不健康的生活方式以及吸煙和飲酒的增加導致心力衰竭、心臟驟停和心律失常的患病率上升，預計北美在預測期內將佔據最大的市場份額。. 此外，該地區存在適當的報銷政策也是推動市場擴張的主要因素之一。 在美國，大多數人肥胖且易患心血管疾病，這可能會促進市場增長。

複合年增長率最高的地區：

由於主要市場參與者在該地區國家/地區的活動增加，預計亞太地區在預測期內的複合年增長率最高。 在印度和中國等新興國家，由於醫療保健基礎設施的快速發展和可支配收入的增加，預計對電生理設備的需求將增加。 此外，醫療基礎設施的快速發展和不斷上升的醫療支出預計將推動該地區行業領先公司的投資。

主要發展：

2022 年 1 月，雅培獲得了美國食品和藥物管理局 (FDA) 對採用 EnSite 全極技術 (OT) 的 EnSite X EP 系統的許可。 它是一個新的心臟繪圖平台，可在美國和歐洲使用，旨在幫助醫生更好地治療異常心律。 該系統創建了一個非常詳細的心臟三維圖，幫助醫生識別出現異常節律的心臟區域，然後進行治療。

2021 年 10 月，Boston Scientific, Inc. 達成最終協議，以 17.5 億美元收購 Bayliss Medical Company, Inc.。 此次收購將有助於波士頓科學公司。

2020 年 12 月，Acutus 宣佈在歐洲推出帶有 CE 標誌的 AcQBlate 力傳感消融系統。 AcQBlate 力傳感消融系統採用市售的金頭灌注力敏感射頻消融導管設計，用於電生理標測和射頻消融。

本報告內容

  • 區域和國家/地區細分市場份額評估
  • 向新進入者提出戰略建議
  • 2020、2021、2022、2025 和 2028 年的綜合市場數據
  • 市場趨勢（驅動因素、制約因素、機會、威脅、挑戰、投資機會、建議）
  • 根據市場預測在關鍵業務領域提出戰略建議
  • 競爭格局映射關鍵共同趨勢。
  • 公司簡介，包括詳細的戰略、財務狀況和近期發展
  • 映射最新技術進步的供應鏈趨勢

免費定制優惠：

購買此報告的客戶將獲得以下免費定制選項之一：

  • 公司簡介
    • 其他市場參與者的綜合概況（最多 3 家公司）
    • 主要參與者的 SWOT 分析（最多 3 家公司）
  • 區域細分
    • 根據客戶的要求對主要國家/地區的市場估計/預測/複合年增長率（注意：基於可行性檢查）。
  • 競爭基準
    • 根據產品組合、區域影響力和戰略聯盟對主要參與者進行基準測試

內容

第 1 章執行摘要

第二章前言

  • 概覽
  • 利益相關者
  • 調查範圍
  • 調查方法
    • 數據挖掘
    • 數據分析
    • 數據驗證
    • 研究方法
  • 調查來源
    • 主要研究來源
    • 二級研究來源
    • 假設

第三章市場趨勢分析

  • 司機
  • 約束因素
  • 機會
  • 威脅
  • 產品分析
  • 最終用戶分析
  • 新興市場
  • COVID-19 的影響

第 4 章波特五力分析

  • 供應商的議價能力
  • 買家的議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第 5 章全球電生理學市場：按產品分類

  • EP 實驗設備
    • EP 遠程轉向系統
    • EP X射線系統
    • 3D 映射系統
    • EP錄音系統
    • 其他 EP 實驗室設備
  • EP 診斷導管
    • 固定診斷導管
    • 超聲電生理診斷導管
    • 常規 EP 診斷導管
    • 可控診斷導管
    • 先進的電生理診斷導管
  • EP 消融導管
    • 常規高頻消融導管
    • 高頻消融導管
    • 灌注頭高頻消融導管
    • 激光燒蝕系統
    • 用於導航的高級地圖配件
    • 微波消融系統
  • 訪問設備
  • 其他產品

第 6 章全球電生理學市場：按適應症分類

  • 房室結折返性心動過速 (AVNRT)
  • 心房顫動 (AF)
  • 沃爾夫帕金森-懷特綜合症 (WPW)
  • 心房撲動
  • 其他適應症

第 7 章全球電生理學市場：按最終用戶分類

  • 門診手術中心
  • 醫院和心臟中心
  • 其他最終用戶

第 8 章。全球電生理學市場：按地區

  • 北美
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 意大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 新西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲
  • 中東和非洲
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國
    • 卡塔爾
    • 南非
    • 其他中東和非洲地區

第九章主要進展

  • 合同、夥伴關係、協作和合資企業
  • 收購與合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章公司簡介

  • Japan LifeLine Co., Ltd.
  • MicroPort Scientific Corporation
  • Osypka Medical
  • Abbott
  • GE Healthcare
  • Siemens Healthcare GmbH
  • APN Health, LLC
  • Koninklijke Philips N.V.
  • Medtronic
  • Stereotaxis, Inc.
  • Johnson & Johnson
  • Japan LifeLine Co., Ltd.
  • Boston Scientific Corporation
  • Acutus Medical, Inc.
Product Code: SMRC23056

According to Stratistics MRC, the Global Electrophysiology Market is accounted for $7.57 billion in 2022 and is expected to reach $14.47 billion by 2028 growing at a CAGR of 11.4% during the forecast period. Electrophysiology (EP) is a scientific discipline that investigates electrical activity in the body. It is also known as invasive cardiac electrophysiology, and it is a series of tests that analyse the electrical activity of the heart. It is used to diagnose and treat cardiac rhythm disorders or arrhythmias by measuring the electrical system or activity of the heart. During the test, catheters and wire electrodes are utilised to assess electrical activity in blood vessels that lead to the heart.

According to the World Obesity Atlas 2022, 1 in 3 men (34.41%) and nearly two-fifths of women (39.72%) are expected to have a BMI of 30kg/m2 by 2030 in the Americas area.

Market Dynamics:

Driver:

The increasing prevalence of heart arrhythmias, ophthalmic issues, and epilepsy

The introduction of innovative technologies such as cryoablation, laser ablation, ultrasonic ablation, and enhanced mapping technologies is expected to increase the global electrophysiology market over the forecast period. The market is also being fueled by the increased prevalence of heart failure (HF) and cardiac arrest cases among millennials as a result of lifestyle choices such as smoking and excessive alcohol consumption. Furthermore, smaller EP monitoring systems have raised demand for these devices in the worldwide electrophysiology industry, particularly during the COVID-19 period. As a result, the cardiac rhythm and failure divisions are paying careful attention to remote monitoring and the programming capabilities of implanted electrophysiology (EP) devices.

Restraint:

High cost

The cost of constructing the EP laboratory has risen significantly over the years due to variables such as healthcare provider consolidation, growing expenses due to the usage of complicated medical treatments, changing government restrictions, and limited resources. This is limiting the penetration of these goods, despite the fact that knowledge of arrhythmia and the usefulness of electrophysiological products to treat arrhythmia is increasing in various nations.

Opportunity:

Rising number of emerging markets

Emerging markets are expected to offer significant growth opportunities for players in this market, owing to their increasing patient population, rising adoption of cardiac mapping systems, growing awareness of CVDs, rising disposable incomes, improving healthcare infrastructure, and comparatively lenient guidelines when compared to developed countries. During the last decade, emerging countries have seen a steady increase in the number of surgical procedures, driven by a larger target patient population, an increase in CVD-related fatalities, and increased medical tourism.

Threat:

Refurbished devices

The rising demand for refurbished products presents a significant challenge for market participants, particularly small producers. To enhance their market position and build a significant user base for their electrophysiological goods, market players must either drop their pricing or develop better or more advanced technologies that can answer the market's unmet needs.

COVID-19 Impact:

The unexpected breakout of the COVID-19 pandemic has had a mixed influence on the worldwide medical equipment business. Some categories suffered an overall negative impact as a result of the global drop in the number of patient visits to hospitals. Patients with pre-existing cardiac disease who are exposed to COVID-19, on the other hand, are more likely to experience a heart attack or develop congestive heart failure. The decline has led to limited demand for electrophysiology devices, hampering the growth of the market. Additionally, key market players operating in the market witnessed decline in the revenues generated from these devices in the first half of 2020.

The EP laboratory devices segment is expected to be the largest during the forecast period

The EP laboratory devices segment is estimated to have a lucrative growth, Due to the increasing public-private funding for the development of novel electrophysiology recording systems, the rising number of RF ablation procedures, the cost-effectiveness of RF ablation procedures in comparison to other ablation techniques, and the expanding availability of these products in major markets. EP laboratory devices are further subdivided into EP X-Ray systems, 3D mapping systems, EP recording systems, EP remote steering systems, and others.

The atrial fibrillation (AF) segment is expected to have the highest CAGR during the forecast period

The atrial fibrillation (AF) segment is anticipated to witness the highest CAGR growth during the forecast period. Atrial fibrillation (AF), commonly known as AFib, is one of the most prevalent kinds of arrhythmia, resulting in irregular and fast heart rhythms. It happens when rapid electric signals drive the upper chamber of the heart to contract quickly, preventing the atria from pumping blood into the ventricles regularly, resulting in blood clots. Atrial fibrillation patients are more likely to get serious heart issues such as strokes and heart failure. AFib contributes to nearly one in every six strokes.

Region with highest share:

North America is projected to hold the largest market share during the forecast period because of the rising prevalence of heart failure (HF), cardiac arrest, and cardiac arrhythmia as a result of unhealthy lifestyles and increased smoking and alcohol intake. The presence of proper reimbursement policies in the region is also one of the primary factors likely to drive market expansion. While the majority of the population in America is obese, they are predisposed to cardiovascular disease, which is likely to boost market growth.

Region with highest CAGR:

Asia Pacific is projected to have the highest CAGR over the forecast period, owing to increasing activities by key market players in countries in the region. The fast growth of healthcare infrastructure and rising disposable income in developing countries such as India and China are expected to drive up demand for electrophysiology devices. Furthermore, it is projected that top industry companies in the region will boost their investment due to the region's fast rising healthcare infrastructure and growing healthcare spending.

Key players in the market:

Some of the key players profiled in the Electrophysiology Market include Japan LifeLine Co., Ltd., MicroPort Scientific Corporation, Osypka Medical, Abbott, GE Healthcare, Siemens Healthcare GmbH, APN Health, LLC, Koninklijke Philips N.V., Medtronic, Stereotaxis, Inc., Johnson & Johnson, Japan LifeLine Co., Ltd., Boston Scientific Corporation and Acutus Medical, Inc.

Key Developments:

In January 2022, Abbott has received the U.S. Food and Drug Administration for its EnSite X EP System with EnSite Omnipolar Technology (OT). It is a new cardiac mapping platform available in the US and across Europe that is designed to help physicians better treat abnormal heart rhythms. The system creates highly detailed three-dimensional maps of the heart to help physicians identify and then treat areas of the heart where abnormal rhythms originate.

In October 2021, Boston Scientific Corporation has entered into a definitive agreement to acquire Baylis Medical Company Inc. for $1.75 billion. The acquisition will help Boston Scientific.

In December 2020, Acutus has announced the launch of their AcQBlate Force Sensing Ablation System in Europe after getting the CE Mark. The AcQBlate Force Sensing Ablation System, designed with commercially available gold-tipped, irrigated, force-sensing radiofrequency ablation catheter, it is used for electrophysiology mapping and RF ablation.

Products Covered:

  • EP laboratory devices
  • EP diagnostic catheters
  • EP ablation catheters
  • Access devices
  • Other Products

Indications Covered:

  • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • Atrial fibrillation (AF)
  • Wolff-Parkinson-White Syndrome (WPW)
  • Atrial flutter
  • Other Indications

End Users Covered:

  • Ambulatory surgery centers
  • Hospitals & cardiac centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2020, 2021, 2022, 2025, and 2028
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 End User Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Electrophysiology Market, By Product

  • 5.1 Introduction
  • 5.2 EP laboratory devices
    • 5.2.1 EP remote steering systems
    • 5.2.2 EP X-Ray systems
    • 5.2.3 3D mapping systems
    • 5.2.4 EP recording systems
    • 5.2.5 Other EP laboratory devices
  • 5.3 EP diagnostic catheters
    • 5.3.1 Fixed diagnostic catheters
    • 5.3.2 Ultrasound EP diagnostic catheters
    • 5.3.3 Conventional EP diagnostic catheters
    • 5.3.4 Steerable diagnostic catheters
    • 5.3.5 Advanced EP diagnostic catheters
  • 5.4 EP ablation catheters
    • 5.4.1 Conventional radiofrequency ablation catheters
    • 5.4.2 Radiofrequency ablation catheters
    • 5.4.3 Irrigated-tip radiofrequency ablation catheters
    • 5.4.4 Laser ablation systems
    • 5.4.5 Navigational advanced mapping accessories
    • 5.4.6 Microwave ablation systems
  • 5.5 Access devices
  • 5.6 Other Products

6 Global Electrophysiology Market, By Indication

  • 6.1 Introduction
  • 6.2 Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • 6.3 Atrial fibrillation (AF)
  • 6.4 Wolff-Parkinson-White Syndrome (WPW)
  • 6.5 Atrial flutter
  • 6.6 Other Indications

7 Global Electrophysiology Market, By End User

  • 7.1 Introduction
  • 7.2 Ambulatory surgery centers
  • 7.3 Hospitals & cardiac centers
  • 7.4 Other End Users

8 Global Electrophysiology Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Japan LifeLine Co., Ltd.
  • 10.2 MicroPort Scientific Corporation
  • 10.3 Osypka Medical
  • 10.4 Abbott
  • 10.5 GE Healthcare
  • 10.6 Siemens Healthcare GmbH
  • 10.7 APN Health, LLC
  • 10.8 Koninklijke Philips N.V.
  • 10.9 Medtronic
  • 10.10 Stereotaxis, Inc.
  • 10.11 Johnson & Johnson
  • 10.12 Japan LifeLine Co., Ltd.
  • 10.13 Boston Scientific Corporation
  • 10.14 Acutus Medical, Inc.

List of Tables

  • Table 1 Global Electrophysiology Market Outlook, By Region (2020-2028) ($MN)
  • Table 2 Global Electrophysiology Market Outlook, By Product (2020-2028) ($MN)
  • Table 3 Global Electrophysiology Market Outlook, By EP laboratory devices (2020-2028) ($MN)
  • Table 4 Global Electrophysiology Market Outlook, By EP remote steering systems (2020-2028) ($MN)
  • Table 5 Global Electrophysiology Market Outlook, By EP X-Ray systems (2020-2028) ($MN)
  • Table 6 Global Electrophysiology Market Outlook, By 3D mapping systems (2020-2028) ($MN)
  • Table 7 Global Electrophysiology Market Outlook, By EP recording systems (2020-2028) ($MN)
  • Table 8 Global Electrophysiology Market Outlook, By Other EP laboratory devices (2020-2028) ($MN)
  • Table 9 Global Electrophysiology Market Outlook, By EP diagnostic catheters (2020-2028) ($MN)
  • Table 10 Global Electrophysiology Market Outlook, By Fixed diagnostic catheters (2020-2028) ($MN)
  • Table 11 Global Electrophysiology Market Outlook, By Ultrasound EP diagnostic catheters (2020-2028) ($MN)
  • Table 12 Global Electrophysiology Market Outlook, By Conventional EP diagnostic catheters (2020-2028) ($MN)
  • Table 13 Global Electrophysiology Market Outlook, By Steerable diagnostic catheters (2020-2028) ($MN)
  • Table 14 Global Electrophysiology Market Outlook, By Advanced EP diagnostic catheters (2020-2028) ($MN)
  • Table 15 Global Electrophysiology Market Outlook, By EP ablation catheters (2020-2028) ($MN)
  • Table 16 Global Electrophysiology Market Outlook, By Conventional radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 17 Global Electrophysiology Market Outlook, By Radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 18 Global Electrophysiology Market Outlook, By Irrigated-tip radiofrequency ablation catheters (2020-2028) ($MN)
  • Table 19 Global Electrophysiology Market Outlook, By Laser ablation systems (2020-2028) ($MN)
  • Table 20 Global Electrophysiology Market Outlook, By Navigational advanced mapping accessories (2020-2028) ($MN)
  • Table 21 Global Electrophysiology Market Outlook, By Microwave ablation systems (2020-2028) ($MN)
  • Table 22 Global Electrophysiology Market Outlook, By Access devices (2020-2028) ($MN)
  • Table 23 Global Electrophysiology Market Outlook, By Other Products (2020-2028) ($MN)
  • Table 24 Global Electrophysiology Market Outlook, By Indication (2020-2028) ($MN)
  • Table 25 Global Electrophysiology Market Outlook, By Atrioventricular Nodal Reentry Tachycardia (AVNRT) (2020-2028) ($MN)
  • Table 26 Global Electrophysiology Market Outlook, By Atrial fibrillation (AF) (2020-2028) ($MN)
  • Table 27 Global Electrophysiology Market Outlook, By Wolff-Parkinson-White Syndrome (WPW) (2020-2028) ($MN)
  • Table 28 Global Electrophysiology Market Outlook, By Atrial flutter (2020-2028) ($MN)
  • Table 29 Global Electrophysiology Market Outlook, By Other Indications (2020-2028) ($MN)
  • Table 30 Global Electrophysiology Market Outlook, By End User (2020-2028) ($MN)
  • Table 31 Global Electrophysiology Market Outlook, By Ambulatory surgery centers (2020-2028) ($MN)
  • Table 32 Global Electrophysiology Market Outlook, By Hospitals & cardiac centers (2020-2028) ($MN)
  • Table 33 Global Electrophysiology Market Outlook, By Other End Users (2020-2028) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.